ADVERTISEMENT

Video blog: HER2-targeted agents

BY DEBU TRIPATHY
PUBLISHED SATURDAY, DECEMBER 10, 2011
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
Dr. Debu Tripathy explains the HER2 pathway's involvement in breast cancer and how new investigational drugs, including pertuzumab and TDM1, as well as combinations of new and approved drugs are targeting this pathway.



Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
ADVERTISEMENT
Cure Connections
$auto_registration$